🇺🇸 FDA
Patent

US 11273130

Methods of delivering a neuroprotective polypeptide to the central nervous system

granted A61KA61K38/26A61K47/34

Quick answer

US patent 11273130 (Methods of delivering a neuroprotective polypeptide to the central nervous system) held by The United States, as represented by the Secretary Department of Health and Human Services expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States, as represented by the Secretary Department of Health and Human Services
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K38/26, A61K47/34, A61K9/0019, A61K9/16